Medtronic today introduced a new approach to minimally invasive spinal fusion surgery that the company says allows the procedure to be performed through smaller incisions in the middle lower back. The MIDLF™ system is the latest in a series of procedural solutions in the medical device maker’s MAST portfolio for minimally invasive treatment of spinal […]
Neurotechnology pain-relief device company SPR Therapeutics has increased its series A round of investment to $1 million and hopes to push the number up to $2 million, according to a regulatory document. CEO Maria Bennett said earlier this year that Cleveland-area SPR was targeting a $2 million round to beef up its sales and marketing […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Israeli pain-relief neurostimulation device company Nervomatrix has received a $3.5 million series A investment and is planning to set up its North American sales and marketing headquarters in Akron, Ohio. The funding comes entirely from Akron-based Everett Partners, and the Israeli company will use it to establish its base in Akron, and fund product enhancements […]
Medical device company TranS1 (NASDAQ:TSON), which focuses on devices that treat degenerative spinal conditions, has raised about $18.3 million in net proceeds from a stock offering intended to finance clinical trials. The Wilmington, North Carolina-based company priced the stock offering of 6.2 million shares last week. The stock offering follows the May filing of a […]
Medical device company TranS1 is moving forward with plans to raise up to $20.1 million through a stock offering. The Wilmington, North Carolina-based company today priced its offering of 6.2 million shares at $3.25 per share, a 12 percent discount from the stock’s previous closing price of $3.70. But in midday trading, TranS1 stock was […]
A few years ago, the Cincinnati brain and spine surgery clinic that Michael Gilligan oversaw was having problems with patient access. Patients at Mayfield Clinic sometimes had to wait two months for appointments, and often when they came in to consult with a surgeon, the surgeon found their conditions would be better solved through some […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Ohio State University has received a five-year, $1.7 million grant from the federal government for a study into spinal cord injuries. Specifically, OSU researchers will study the chemical signals that drive re-growth of damaged pathways after spinal cord injury. The researchers hope to find that altering cellular behavior promotes repair of an injured spinal cord, […]
Medtronic (NYSE:MDT) on Monday dealt with the U.S. Food and Drug Administration recall of a battery problem in one of its drug delivery pumps. On the same day, it announced a new set of screws and products for bone grafts and other kinds of cosmetic dentistry. The FDA announced a Class I recall of the […]
When Medtronic (NYSE:MDT) executives reported results of its first fiscal quarter Tuesday, Chairman and CEO Omar Ishrak found it necessary to stress the steps the company has taken to address the controversy surrounding the Infuse bone growth product. Not surprising since Infuse sales took a real beating in the quarter. In late June, an entire […]
OrthoCor Medical, a Minnesota knee brace manufacturer, announced Tuesday that the U.S. Food and Drug Administration has cleared its Alleva line of heat and cold wraps for knee and lower back pain among other areas. With the FDA clearance, the products intended to alleviate pain in several areas, including the knee, lower back, ankle, wrist, […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
If a Wall Street analyst’s revenue forecast turns out to be correct, Medtronic (NYSE:MDT) shareholders will have little to cheer about on Aug. 23 when the medical device company announces its first fiscal quarter results. Citi analyst Matthew Dodds published a note Monday that said he expects Medtronic will now garner $3.95 billion in revenue […]
With all the turmoil in the US healthcare market, a port in the storm is not easy to find. A port that can accommodate an outsized tanker ship like Medtronic is even harder to locate. With two back-to-back acquisitions last month of Peak Surgical and Salient Surgical, the S.S. Medtronic took refuge in Surgery Harbor, committing nearly $600 million (net of previous ownership stakes) in a single day to nestle in with the hulking barges of Covidien and J&J.
Medtronic (NYSE:MDT) announced Wednesday that it is offering a $2.5 million grant to Yale researchers who will independently review the safety of the company’s controversial Infuse bone graft product. The money will cover two reviews of the so-called recombinant bone morphogenic protein-2 (rhBMP-2) product, which stimulates bone formation. Yale expects to complete the reviews in […]
The latest group purchasing organization deal by Upper Midwest Consolidated Services Center thumbs a nose at Medtronic’s (NYSE:MDT) controversial decision to cut several GPO deals earlier this year by replacing a Medtronic contract with a St. Jude Medical (NYSE:STJ) deal. Irving, Texas-based UMCSC announced a one-year contract for cardiac rhythm management products with St. Jude […]
Analysts at Standard & Poor’s changed their outlook for Medtronic Inc. (NYSE:MDT) from stable to negative due to continuing softness in the cardiac rhythm management market and pressures in the company’s spine business resulting from the Infuse controversy. It is the second outlook change from a major credit ratings agency the company has received in […]